Senna-plus Tablet
Product Images NDC 57896-555

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Senna-plus (NDC 57896-555). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Geri-care Pharmaceutical Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (555)

Drug Facts panel for SENNA-PLUS tablets containing Sennosides 8.6 mg and Docusate Sodium 50 mg. The label presents active ingredients, purpose, uses for occasional constipation relief, warnings, directions by age group, and other product information including inactive ingredients and storage instructions. The label stresses not exceeding 8 tablets in 24 hours and advises consultation with a doctor for children under 12 and other health conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.